Experienced in Neonatal Onset Multisystem Inflammatory Disease

Karsten Weller

Berlin, BE, DE 
Experienced in Neonatal Onset Multisystem Inflammatory Disease
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Karsten Weller practices in Berlin, Germany. Mr. Weller is rated as an Experienced expert by MediFind in the treatment of Neonatal Onset Multisystem Inflammatory Disease. His top areas of expertise are Hives, Chronic Spontaneous Urticaria (CSU), Angioedema, and Hereditary Angioedema.

His clinical research consists of co-authoring 165 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Neonatal Onset Multisystem Inflammatory Disease.

Gender
Male

Locations

Berlin, BE, Germany
Other Locations
Mainz, RP, Germany
Nuernberg, BY, Germany
Erlangen, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multi-center, Randomized, Double Blind, Dose Escalating Phase III Study on the Efficacy, Safety and Long Term Outcome of Continuous vs. on Demand Treatment of Chronic Spontaneous Urticaria With Rupatadine.
A Multi-center, Randomized, Double Blind, Dose Escalating Phase III Study on the Efficacy, Safety and Long Term Outcome of Continuous vs. on Demand Treatment of Chronic Spontaneous Urticaria With Rupatadine.
Enrollment Status: Terminated
Publish Date: September 17, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Single-center, Double-blind Placebo-controlled Parallel Group Phase II Study of the Efficacy and Safety of Rilonacept in Subjects With Cold Contact Urticaria (CCU)
A Single-center, Double-blind Placebo-controlled Parallel Group Phase II Study of the Efficacy and Safety of Rilonacept in Subjects With Cold Contact Urticaria (CCU)
Enrollment Status: Completed
Publish Date: July 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

165 Total Publications

Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center.
Temporal Trends in the Course and Management of Chronic Urticaria at a European Tertiary Center.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: July 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Weller's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile